Physiol. Genomics Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics 33: 240-256, 2008. First published February 12, 2008; doi:10.1152/physiolgenomics.00242.2007
1094-8341/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
33/2/240    most recent
00242.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Liang, W. S.
Right arrow Articles by Stephan, D. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liang, W. S.
Right arrow Articles by Stephan, D. A.
Received 12 October 2007; accepted in final form 8 February 2008.
Physiological Genomics 33:240-256 (2008)
1094-8341/08 $8.00 © 2008 American Physiological Society

Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set

Winnie S. Liang1,7, Travis Dunckley1,7, Thomas G. Beach2,7, Andrew Grover2,7, Diego Mastroeni2,7, Keri Ramsey1, Richard J. Caselli3,7, Walter A. Kukull4, Daniel McKeel5, John C. Morris5, Christine M. Hulette6, Donald Schmechel6, Eric M. Reiman1,7,8, Joseph Rogers2,7 and Dietrich A. Stephan1,7

1 Neurogenomics Division, Translational Genomics Research Institute, Phoenix, Arizona
2 Sun Health Research Institute, Sun City, Arizona
3 Department of Neurology, Mayo Clinic, Scottsdale, Arizona
4 National Alzheimer's Coordinating Center, Seattle, Washington
5 Washington University Alzheimer's Disease Research Center, St. Louis, Missouri
6 Duke University Alzheimer's Disease Research Center, Durham, North Carolina
7 Arizona Alzheimer's Disease Consortium, Phoenix, Arizona
8 Banner Alzheimer's Institute, Phoenix, Arizona

Alzheimer's Disease (AD) is the most widespread form of dementia during the later stages of life. If improved therapeutics are not developed, the prevalence of AD will drastically increase in the coming years as the world's population ages. By identifying differences in neuronal gene expression profiles between healthy elderly persons and individuals diagnosed with AD, we may be able to better understand the molecular mechanisms that drive AD pathogenesis, including the formation of amyloid plaques and neurofibrillary tangles. In this study, we expression profiled histopathologically normal cortical neurons collected with laser capture microdissection (LCM) from six anatomically and functionally discrete postmortem brain regions in 34 AD-afflicted individuals, using Affymetrix Human Genome U133 Plus 2.0 microarrays. These regions include the entorhinal cortex, hippocampus, middle temporal gyrus, posterior cingulate cortex, superior frontal gyrus, and primary visual cortex. This study is predicated on previous parallel research on the postmortem brains of the same six regions in 14 healthy elderly individuals, for which LCM neurons were similarly processed for expression analysis. We identified significant regional differential expression in AD brains compared with control brains including expression changes of genes previously implicated in AD pathogenesis, particularly with regard to tangle and plaque formation. Pinpointing the expression of factors that may play a role in AD pathogenesis provides a foundation for future identification of new targets for improved AD therapeutics. We provide this carefully phenotyped, laser capture microdissected intraindividual brain region expression data set to the community as a public resource.

expression profiling; neuron; Affymetrix microarrays; laser capture microdissection







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.